Q4 still has it running at a loss, even with relatively minor development costs, the market reaction seems warranted.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game